Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
CXCR6+ CD127– Tr1 cells balance immunity and persistence in Plasmodium falciparum infection
Jason Nideffer, Florian Bach, Steven Strubbe, Luis Lopez, Maato Zedi, Felistas Nankya, Jessica Briggs, Kattria van der Ploeg, Kenneth Musinguzi, Soyeon Kim, Aracely Garcia Romero, Arefin Keya, Kylie Camanag, Savannah Lewis, Muhammad Abdelbasset, Bing Wang, Allison Boss, Evelyn Nansubuga, Joaniter I. Nankabirwa, Emmanuel Arinaitwe, Saki Takahashi, Grant Dorsey, Bryan Greenhouse, Isabel Rodriguez-Barraquer, Moses R. Kamya, Rosa Bacchetta, Isaac Ssewanyana, Ashraful Haque, Maria Grazia Roncarolo, Prasanna Jagannathan
Jason Nideffer, Florian Bach, Steven Strubbe, Luis Lopez, Maato Zedi, Felistas Nankya, Jessica Briggs, Kattria van der Ploeg, Kenneth Musinguzi, Soyeon Kim, Aracely Garcia Romero, Arefin Keya, Kylie Camanag, Savannah Lewis, Muhammad Abdelbasset, Bing Wang, Allison Boss, Evelyn Nansubuga, Joaniter I. Nankabirwa, Emmanuel Arinaitwe, Saki Takahashi, Grant Dorsey, Bryan Greenhouse, Isabel Rodriguez-Barraquer, Moses R. Kamya, Rosa Bacchetta, Isaac Ssewanyana, Ashraful Haque, Maria Grazia Roncarolo, Prasanna Jagannathan
View: Text | PDF
Research Article Immunology Infectious disease

CXCR6+ CD127– Tr1 cells balance immunity and persistence in Plasmodium falciparum infection

  • Text
  • PDF
Abstract

Plasmodium falciparum (Pf) induces the clonal expansion of antigen-specific type 1 regulatory T (Tr1) cells capable of long-term memory. Tr1 cells comprise nearly 90% of the Pf blood stage antigen-specific CD4+ T cell pool in children. Though, whether Tr1 cells contribute to protection from malaria remains undetermined. To address this critical knowledge gap, we first performed scRNA-seq on gated cell populations and validated CXCR6+ CD127– as new phenotypic markers to enrich for bona fide Tr1 cells. Importantly, these Tr1 cells potently suppressed the proliferation of other CD4+ T cells in vitro via IL-10 secretion. Among children living in malaria-endemic Uganda, CXCR6+ CD127– Tr1 cells were the dominant responding subset to Pf-infected red blood cell stimulation in vitro. They also rapidly expanded following malaria and expressed IL-10 and IFN-γ during infection in vivo. Tr1 abundance correlated with plasma concentrations of granzyme A, IFN-γ, IL-10, and LAG3, suggesting that these cells act systemically. Higher CXCR6+ CD127– Tr1 cell frequencies correlated with a lower probability of symptoms given parasitemia but were also associated with delayed parasite clearance among untreated, asymptomatic children. These data suggest that Tr1 cells help mediate clinical immunity to malaria but may also facilitate parasite persistence through mechanisms of immune regulation.

Authors

Jason Nideffer, Florian Bach, Steven Strubbe, Luis Lopez, Maato Zedi, Felistas Nankya, Jessica Briggs, Kattria van der Ploeg, Kenneth Musinguzi, Soyeon Kim, Aracely Garcia Romero, Arefin Keya, Kylie Camanag, Savannah Lewis, Muhammad Abdelbasset, Bing Wang, Allison Boss, Evelyn Nansubuga, Joaniter I. Nankabirwa, Emmanuel Arinaitwe, Saki Takahashi, Grant Dorsey, Bryan Greenhouse, Isabel Rodriguez-Barraquer, Moses R. Kamya, Rosa Bacchetta, Isaac Ssewanyana, Ashraful Haque, Maria Grazia Roncarolo, Prasanna Jagannathan

×

Figure 4

Cytokine production by memory CD4+ T cell subsets following stimulation.

Options: View larger image (or click on image) Download as PowerPoint
Cytokine production by memory CD4+ T cell subsets following stimulation....
(A) Longitudinal sampling and experimental timeline depicting how samples were provided by children and adults from Uganda enrolled in MUSICAL. Sampling occurred in the context of symptomatic and asymptomatic infections experienced by the same individual. Plasma and PBMCs derived from the same blood sample were analyzed by flow cytometry and NULISA, respectively. (B) Histogram depicting the ages (at diagnosis) of children followed in this study. Timepoints from symptomatic and asymptomatic infections are included for each individual. Lines represent smoothed average counts. (C–F) The percentage of memory CD4+ T cells that belonged to a given subset (defined by surface markers) and produced IL-10 (C and D) or IFN-γ (E and F) in response to stimulation with PMA and ionomycin (C and E) or in response to iRBC stimulation (D and F). (G and H) The percentage of CXCR5+ PD-1+ cTfh or cytokine-expressing (G, IL-10; H, IFN-γ) CXCR5+ PD-1+ cTfh that were also CXCR6+ CD127– (stimulated with iRBCs). (I and J) The percentage of CXCR6+ CD127– Tr1 cells and cytokine-expressing (I, IL-10; J, IFN-γ) CXCR6+ CD127– Tr1 cells that were also CXCR5+ PD-1+. For single comparisons, significance was determined via paired T tests. For, multiple pair-wise comparisons (C–F), significance was determined using a Wald test (including study participant as a random intercept) followed by P value adjustment using the Benjamini-Hochberg false discovery rate (FDR) procedure. All significant comparisons are annotated; **P < 0.01; ***P < 0.001. For all plots, data points represent an aggregate of measurements from a single MUSICAL participant sampled at multiple timepoints before, during, and after symptomatic and asymptomatic infections.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts